Literature DB >> 6586487

Distribution of terbutaline.

A Ryrfeldt, C H Ramsay.   

Abstract

Whole body autoradiographic studies performed with [3H]terbutaline after intravenous and oral administration in mice revealed that the tissue and organ radioactivity was similar to or lower than the blood radioactivity with the exception of excretory organs. This can be explained by the hydrophilic nature of terbutaline and its metabolites. However, it is noteworthy that the organ (e.g. lung and heart) concentrations of unchanged terbutaline can exceed those found in serum severalfold. This was most obvious when the drug was administered via the respiratory tract and the effect became more pronounced with time after administration. It may be explained by a more rapid clearance of drug from the blood than redistribution from tissues into the blood.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6586487

Source DB:  PubMed          Journal:  Eur J Respir Dis Suppl        ISSN: 0106-4347


  8 in total

1.  Investigation of distribution and elimination of terbutaline sulfate in the perfused rat liver preparation.

Authors:  Selma Sahin; Yasemin Karabey
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2010-09       Impact factor: 2.441

2.  Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate.

Authors:  L Borgström; L Nyberg; S Jönsson; C Lindberg; J Paulson
Journal:  Br J Clin Pharmacol       Date:  1989-01       Impact factor: 4.335

3.  Terbutaline pharmacokinetics in cows: preliminary data.

Authors:  Melanie J Boileau; Kevin E Washburn; Cyril R Clarke; Robert N Streeter; Lara K Maxwell
Journal:  Can J Vet Res       Date:  2007-01       Impact factor: 1.310

Review 4.  Clinical pharmacokinetics of bambuterol.

Authors:  D S Sitar
Journal:  Clin Pharmacokinet       Date:  1996-10       Impact factor: 6.447

Review 5.  The effect of respiratory disorders on clinical pharmacokinetic variables.

Authors:  A M Taburet; C Tollier; C Richard
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

6.  Bambuterol and terbutaline in human cerebrospinal fluid and plasma.

Authors:  B Rosberg; C Schröder; L Nyberg; J Rosenborg; J E Wirén
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 7.  Pharmacokinetic optimisation of asthma treatment.

Authors:  A M Taburet; B Schmit
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

8.  Prediction of the therapeutic dose for beta-stimulants based on preclinical data: application of oral dosage forms and aerosols to asthmatic patients.

Authors:  K Ito; N Yajima; H Ohtani; Y Yamada; K Nakamura; Y Sawada; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1993-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.